Wikidata

(Q54373489)

English

Double-blind, placebo-controlled, multicenter, randomized, phase IIb neoadjuvant study of letrozole-lapatinib in postmenopausal hormone receptor-positive, human epidermal growth factor receptor 2-negative, operable breast cancer.

scientific article published on 3 March 2014

In more languages

Statements

title
Double-blind, placebo-controlled, multicenter, randomized, phase IIb neoadjuvant study of letrozole-lapatinib in postmenopausal hormone receptor-positive, human epidermal growth factor receptor 2-negative, operable breast cancer. (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24590635
retrieved
28 May 2018
reference URL
http://europepmc.org/abstract/MED/24590635
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q54373489&oldid=1245325851"